10
Dec
2024

Megafine Pharma (P) Ltd.

Exhibitor at CPHI Middle East 2024 stand 2.A78
About Us

MEGAFINE offering Innovative & Integrated API solutions is USFDA, EU-GMP,Australia-TGA, Canada-HC, Korea-MFDS, Japan-PMDA & Mexico-COFEPRIS inspected manufacturer of high quality APIs & Intermediates to Innovators and Generic companies having 26 US-DMFs, 6 CEPs and 350+ global regulatory filings. To support its rapid growth, we have commissioned a NEW API plant with five production blocks at our Vapi site. RECENTLY VALIDATED: Apremilast, Edoxaban, Cariprazine, Teriflunomide, Vortioxetine. NEW DEVELOPMENT: Vibegron .....

  • IN
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Contact info
Event information
CPHI Middle East 2024
  • 10 Dec 2024 - 12 Dec 2024
  • Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
  • Visit us at stand 2.A78

Products Featured at CPHI Middle East 2024